Lymphoscintigraphy for Imaging of the Lymphatic Flow Disorders.
Identifieur interne : 000E36 ( Main/Exploration ); précédent : 000E35; suivant : 000E37Lymphoscintigraphy for Imaging of the Lymphatic Flow Disorders.
Auteurs : Rie Yagi Yoshida [Japon] ; Shuji Kariya [Japon] ; Sangkil Ha-Kawa [Japon] ; Noboru Tanigawa [Japon]Source :
- Techniques in vascular and interventional radiology [ 1557-9808 ] ; 2016.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen, Facteurs de risque, Femelle, Humains, Indice de gravité médicale, Lymphoscintigraphie (), Lymphoscintigraphie (effets indésirables), Lymphoscintigraphie (instrumentation), Maladies lymphatiques (imagerie diagnostique), Maladies lymphatiques (physiopathologie), Maladies lymphatiques (étiologie), Mâle, Pronostic, Radiopharmaceutiques (administration et posologie), Système lymphatique (imagerie diagnostique), Système lymphatique (physiopathologie), Valeur prédictive des tests.
- MESH :
- administration et posologie : Radiopharmaceutiques.
- effets indésirables : Lymphoscintigraphie.
- imagerie diagnostique : Maladies lymphatiques, Système lymphatique.
- physiopathologie : Maladies lymphatiques, Système lymphatique.
- étiologie : Lymphoscintigraphie, Maladies lymphatiques.
- Adulte d'âge moyen, Facteurs de risque, Femelle, Humains, Indice de gravité médicale, Lymphoscintigraphie, Mâle, Pronostic, Valeur prédictive des tests.
English descriptors
- KwdEn :
- Female, Humans, Lymphatic Diseases (diagnostic imaging), Lymphatic Diseases (etiology), Lymphatic Diseases (physiopathology), Lymphatic System (diagnostic imaging), Lymphatic System (physiopathology), Lymphoscintigraphy (adverse effects), Lymphoscintigraphy (instrumentation), Lymphoscintigraphy (methods), Male, Middle Aged, Predictive Value of Tests, Prognosis, Radiopharmaceuticals (administration & dosage), Risk Factors, Severity of Illness Index.
- MESH :
- chemical , administration & dosage : Radiopharmaceuticals.
- adverse effects : Lymphoscintigraphy.
- diagnostic imaging : Lymphatic Diseases, Lymphatic System.
- etiology : Lymphatic Diseases.
- instrumentation : Lymphoscintigraphy.
- methods : Lymphoscintigraphy.
- physiopathology : Lymphatic Diseases, Lymphatic System.
- Female, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Risk Factors, Severity of Illness Index.
Abstract
Lymphoscintigraphy has introduced with the great advantage for diagnostic imaging of the lymphatic flow disorders. Lymphoscintigraphy can be performed in patients of any age, including neonates, and even in patient in critical conditions. The procedure is quite simple, and it needs only subcutaneous injection of small amounts of radiotracers. From subcutaneous tissue the radiotracer is taken by the lymphatic vessels and gives off energy in the form of gamma radiation detected by a gamma camera. Radiotracers rarely cause the allergic reaction and can be administered to the patients with allergy to iodine contrast media. Comparing with the Lipiodol, radiotracers cannot cause pulmonary embolism; therefore, it is safe for the patients with respiratory dysfunction. The objective of this article is to describe the indication, technique, equipment, pitfalls, safety, and effectiveness of lymphoscintigraphy for imaging of the lymphatic flow disorders.
DOI: 10.1053/j.tvir.2016.10.009
PubMed: 27993322
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000455
- to stream PubMed, to step Curation: 000455
- to stream PubMed, to step Checkpoint: 000455
- to stream Ncbi, to step Merge: 008B32
- to stream Ncbi, to step Curation: 008B32
- to stream Ncbi, to step Checkpoint: 008B32
- to stream Main, to step Merge: 000E37
- to stream Main, to step Curation: 000E36
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Lymphoscintigraphy for Imaging of the Lymphatic Flow Disorders.</title><author><name sortKey="Yoshida, Rie Yagi" sort="Yoshida, Rie Yagi" uniqKey="Yoshida R" first="Rie Yagi" last="Yoshida">Rie Yagi Yoshida</name><affiliation wicri:level="1"><nlm:affiliation>Department of Radiology, Kansai Medical University, Hirakata, Osaka, Japan. Electronic address: yagir@hirakata.kmu.ac.jp.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Radiology, Kansai Medical University, Hirakata, Osaka</wicri:regionArea><wicri:noRegion>Osaka</wicri:noRegion></affiliation></author><author><name sortKey="Kariya, Shuji" sort="Kariya, Shuji" uniqKey="Kariya S" first="Shuji" last="Kariya">Shuji Kariya</name><affiliation wicri:level="1"><nlm:affiliation>Department of Radiology, Kansai Medical University, Hirakata, Osaka, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Radiology, Kansai Medical University, Hirakata, Osaka</wicri:regionArea><wicri:noRegion>Osaka</wicri:noRegion></affiliation></author><author><name sortKey="Ha Kawa, Sangkil" sort="Ha Kawa, Sangkil" uniqKey="Ha Kawa S" first="Sangkil" last="Ha-Kawa">Sangkil Ha-Kawa</name><affiliation wicri:level="1"><nlm:affiliation>Department of Radiology, Kansai Medical University, Hirakata, Osaka, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Radiology, Kansai Medical University, Hirakata, Osaka</wicri:regionArea><wicri:noRegion>Osaka</wicri:noRegion></affiliation></author><author><name sortKey="Tanigawa, Noboru" sort="Tanigawa, Noboru" uniqKey="Tanigawa N" first="Noboru" last="Tanigawa">Noboru Tanigawa</name><affiliation wicri:level="1"><nlm:affiliation>Department of Radiology, Kansai Medical University, Hirakata, Osaka, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Radiology, Kansai Medical University, Hirakata, Osaka</wicri:regionArea><wicri:noRegion>Osaka</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:27993322</idno><idno type="pmid">27993322</idno><idno type="doi">10.1053/j.tvir.2016.10.009</idno><idno type="wicri:Area/PubMed/Corpus">000455</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000455</idno><idno type="wicri:Area/PubMed/Curation">000455</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000455</idno><idno type="wicri:Area/PubMed/Checkpoint">000455</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000455</idno><idno type="wicri:Area/Ncbi/Merge">008B32</idno><idno type="wicri:Area/Ncbi/Curation">008B32</idno><idno type="wicri:Area/Ncbi/Checkpoint">008B32</idno><idno type="wicri:Area/Main/Merge">000E37</idno><idno type="wicri:Area/Main/Curation">000E36</idno><idno type="wicri:Area/Main/Exploration">000E36</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Lymphoscintigraphy for Imaging of the Lymphatic Flow Disorders.</title><author><name sortKey="Yoshida, Rie Yagi" sort="Yoshida, Rie Yagi" uniqKey="Yoshida R" first="Rie Yagi" last="Yoshida">Rie Yagi Yoshida</name><affiliation wicri:level="1"><nlm:affiliation>Department of Radiology, Kansai Medical University, Hirakata, Osaka, Japan. Electronic address: yagir@hirakata.kmu.ac.jp.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Radiology, Kansai Medical University, Hirakata, Osaka</wicri:regionArea><wicri:noRegion>Osaka</wicri:noRegion></affiliation></author><author><name sortKey="Kariya, Shuji" sort="Kariya, Shuji" uniqKey="Kariya S" first="Shuji" last="Kariya">Shuji Kariya</name><affiliation wicri:level="1"><nlm:affiliation>Department of Radiology, Kansai Medical University, Hirakata, Osaka, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Radiology, Kansai Medical University, Hirakata, Osaka</wicri:regionArea><wicri:noRegion>Osaka</wicri:noRegion></affiliation></author><author><name sortKey="Ha Kawa, Sangkil" sort="Ha Kawa, Sangkil" uniqKey="Ha Kawa S" first="Sangkil" last="Ha-Kawa">Sangkil Ha-Kawa</name><affiliation wicri:level="1"><nlm:affiliation>Department of Radiology, Kansai Medical University, Hirakata, Osaka, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Radiology, Kansai Medical University, Hirakata, Osaka</wicri:regionArea><wicri:noRegion>Osaka</wicri:noRegion></affiliation></author><author><name sortKey="Tanigawa, Noboru" sort="Tanigawa, Noboru" uniqKey="Tanigawa N" first="Noboru" last="Tanigawa">Noboru Tanigawa</name><affiliation wicri:level="1"><nlm:affiliation>Department of Radiology, Kansai Medical University, Hirakata, Osaka, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Radiology, Kansai Medical University, Hirakata, Osaka</wicri:regionArea><wicri:noRegion>Osaka</wicri:noRegion></affiliation></author></analytic><series><title level="j">Techniques in vascular and interventional radiology</title><idno type="eISSN">1557-9808</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Female</term><term>Humans</term><term>Lymphatic Diseases (diagnostic imaging)</term><term>Lymphatic Diseases (etiology)</term><term>Lymphatic Diseases (physiopathology)</term><term>Lymphatic System (diagnostic imaging)</term><term>Lymphatic System (physiopathology)</term><term>Lymphoscintigraphy (adverse effects)</term><term>Lymphoscintigraphy (instrumentation)</term><term>Lymphoscintigraphy (methods)</term><term>Male</term><term>Middle Aged</term><term>Predictive Value of Tests</term><term>Prognosis</term><term>Radiopharmaceuticals (administration & dosage)</term><term>Risk Factors</term><term>Severity of Illness Index</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Facteurs de risque</term><term>Femelle</term><term>Humains</term><term>Indice de gravité médicale</term><term>Lymphoscintigraphie ()</term><term>Lymphoscintigraphie (effets indésirables)</term><term>Lymphoscintigraphie (instrumentation)</term><term>Maladies lymphatiques (imagerie diagnostique)</term><term>Maladies lymphatiques (physiopathologie)</term><term>Maladies lymphatiques (étiologie)</term><term>Mâle</term><term>Pronostic</term><term>Radiopharmaceutiques (administration et posologie)</term><term>Système lymphatique (imagerie diagnostique)</term><term>Système lymphatique (physiopathologie)</term><term>Valeur prédictive des tests</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Radiopharmaceuticals</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Radiopharmaceutiques</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Lymphoscintigraphy</term></keywords><keywords scheme="MESH" qualifier="diagnostic imaging" xml:lang="en"><term>Lymphatic Diseases</term><term>Lymphatic System</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Lymphoscintigraphie</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphatic Diseases</term></keywords><keywords scheme="MESH" qualifier="imagerie diagnostique" xml:lang="fr"><term>Maladies lymphatiques</term><term>Système lymphatique</term></keywords><keywords scheme="MESH" qualifier="instrumentation" xml:lang="en"><term>Lymphoscintigraphy</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Lymphoscintigraphy</term></keywords><keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr"><term>Maladies lymphatiques</term><term>Système lymphatique</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Lymphatic Diseases</term><term>Lymphatic System</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Lymphoscintigraphie</term><term>Maladies lymphatiques</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Predictive Value of Tests</term><term>Prognosis</term><term>Risk Factors</term><term>Severity of Illness Index</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Facteurs de risque</term><term>Femelle</term><term>Humains</term><term>Indice de gravité médicale</term><term>Lymphoscintigraphie</term><term>Mâle</term><term>Pronostic</term><term>Valeur prédictive des tests</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Lymphoscintigraphy has introduced with the great advantage for diagnostic imaging of the lymphatic flow disorders. Lymphoscintigraphy can be performed in patients of any age, including neonates, and even in patient in critical conditions. The procedure is quite simple, and it needs only subcutaneous injection of small amounts of radiotracers. From subcutaneous tissue the radiotracer is taken by the lymphatic vessels and gives off energy in the form of gamma radiation detected by a gamma camera. Radiotracers rarely cause the allergic reaction and can be administered to the patients with allergy to iodine contrast media. Comparing with the Lipiodol, radiotracers cannot cause pulmonary embolism; therefore, it is safe for the patients with respiratory dysfunction. The objective of this article is to describe the indication, technique, equipment, pitfalls, safety, and effectiveness of lymphoscintigraphy for imaging of the lymphatic flow disorders.</div></front></TEI><affiliations><list><country><li>Japon</li></country></list><tree><country name="Japon"><noRegion><name sortKey="Yoshida, Rie Yagi" sort="Yoshida, Rie Yagi" uniqKey="Yoshida R" first="Rie Yagi" last="Yoshida">Rie Yagi Yoshida</name></noRegion><name sortKey="Ha Kawa, Sangkil" sort="Ha Kawa, Sangkil" uniqKey="Ha Kawa S" first="Sangkil" last="Ha-Kawa">Sangkil Ha-Kawa</name><name sortKey="Kariya, Shuji" sort="Kariya, Shuji" uniqKey="Kariya S" first="Shuji" last="Kariya">Shuji Kariya</name><name sortKey="Tanigawa, Noboru" sort="Tanigawa, Noboru" uniqKey="Tanigawa N" first="Noboru" last="Tanigawa">Noboru Tanigawa</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000E36 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000E36 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:27993322
|texte= Lymphoscintigraphy for Imaging of the Lymphatic Flow Disorders.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:27993322" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |